NCT04114435 Pulmonary Vascular Disease and Cardiac Performance in Extreme Preterm Infants
| NCT ID | NCT04114435 |
| Status | Recruiting |
| Phase | — |
| Sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre |
| Condition | Prematurity; Extreme |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2019-10-12 |
| Primary Completion | 2023-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2019-10-12 with a primary completion date of 2023-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Pulmonary vascular disease and cardiac performance in extreme preterm infants: A prospective cross-sectional study
Eligibility Criteria
Inclusion Criteria: * Infants born at \<29 weeks' gestational age admitted to the NICU * All infants born at \<29 weeks' gestational age followed at MCH clinic after an admission in the NICU for prematurity \<29 weeks Exclusion Criteria: * Congenital heart disease (except an atrial (ASD) or ventricular septal defect (VSD), or a patent ductus arteriosus (PDA)) * Congenital severe lung or airway malformation (choanal atresia, trachea-esophageal fistula or congenital pulmonary airway malformation) * Genetic disorder (Trisomy 21).
Frequently Asked Questions
Who can join the NCT04114435 clinical trial?
This trial is open to participants of all sexes, aged 7 Days or older, up to 5 Years, studying Prematurity; Extreme. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04114435 currently recruiting?
Yes, NCT04114435 is actively recruiting participants. Visit ClinicalTrials.gov or contact McGill University Health Centre/Research Institute of the McGill University Health Centre to inquire about joining.
Where is the NCT04114435 trial being conducted?
This trial is being conducted at Montreal, Canada.
Who is sponsoring the NCT04114435 clinical trial?
NCT04114435 is sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre. The trial plans to enroll 150 participants.